1 Product identity
Ingredient risk
3 ingredients to use with caution
Melatonin 3 mg
BrandDesigns for Health→Non-Nutrient/Non-Botanical Tablet or Pill 7 ingredients 3 caution DSLD #22659Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-06-25
2 Ingredients (7)
IngredientGroupSafety
CelluloseCellulose—
modified Cellulose GumCellulose—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Vitamin B6 — Sensory neuropathy from chronic high-dose B6 (>200 mg/day) — presents as numbness, ataxia. Can be irreversible. Often self-prescribed by patients…
Melatonin 🇯🇵 🇪🇺 🇦🇺 🇩🇪 🇬🇧 — Not approved as food supplement. Classified as pharmaceutical.
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Vitamin B6 — Use with Caution
Melatonin — Use with Caution
⚠ Daytime drowsiness
⚠ May worsen depression
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
5 Data source
DSLD ID22659
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-06-25
6 More from Designs for Health
View Designs for Health Safety Scorecard → 261 products
5-HTP Supreme5-HTP Synergy7-KetoAcetyl L-CarnitineAcnutrolAdrenal Complex7 Cite this page
Vancouver
Pkhakadze G. Melatonin 3 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Sep 01]. Available from: https://supplement.ge/products/melatonin-3-mg-22659/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG